Maren Thomas

MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma.

R. Hartmann, A. Aigner, U. Weirauch, 2011, Cancer research.

RNAi-based anti-cancer strategies - targeting the proto-oncogene PIM1 and oncogenic miRNAs

Maren Thomas, 2013 .

Analysis of Transcriptional Regulation of the Human miR-17-92 Cluster; Evidence for Involvement of Pim-1

R. Hartmann, A. Aigner, Maren Thomas, 2013, International journal of molecular sciences.

PEI-complexed LNA antiseeds as miRNA inhibitors

R. Hartmann, A. Aigner, U. Bakowsky, 2012, RNA biology.

Functional role and therapeutic potential of the pim-1 kinase in colon carcinoma.

R. Hartmann, A. Aigner, U. Weirauch, 2013, Neoplasia.

Therapeutics , Targets , and Chemical Biology MicroRNA Replacement Therapy for miR-145 and miR-33 a Is Efficacious in a Model of Colon Carcinoma

R. Hartmann, A. Aigner, U. Weirauch, 2011 .

The proto-oncogene Pim-1 is a target of miR-33a

D. Gutsch, R. Hartmann, A. Aigner, 2012, Oncogene.

MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma.

R. Hartmann, A. Aigner, U. Weirauch, 2011, Cancer research.